"This action by the FDA has been a long time coming," says Laurie Beyranevand, director of the Center for Agriculture and ...
The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious ...
INNOVATE Corp. (VATE) announced that the U.S. FDA has approved the MediBeacon TGFR for the assessment of kidney function in patients with normal ...
VERIFY answers four questions about the common food additive red dye No. 3, including what products contain it and if the FDA ...
The FDA revokes FD&C Red No. 3 authorization due to cancer concerns under the Delaney Clause, impacting food and drug ...
Study to be conducted under $3.6 million NIH grant DENVER, Jan. 13, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), ...
SeaStar Medical (ICU) announced that the U.S. FDA has approved an investigational device exemption application to evaluate the safety and ...
In 2024, the General Assembly passed House Bill 11, which limits vape products that can be sold in Kentucky.
Almost exactly 10 years after the FDA’s initial FDA approval for Bristol Myers Squibb’s Opdivo as the first PD-1 inhibitor in the U.S., the agency has cleared an under-the-skin version of the ...
Subcutaneous nivolumab and hyaluronidase-nvhy is FDA-approved for adult solid tumors, offering a new administration route for PD-1 inhibitors. The phase 3 CheckMate-67T trial confirmed ...